Glimepiride Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
Condition:   Diabetes Mellitus, Type II Interventions:   Drug: Empagliflozin;   Drug: Glimepiride;   Drug: Empagliflozin placebo;   Drug: Glimepiride placebo Sponsor:   Hannover Medical School Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2016 Category: Research Source Type: clinical trials